Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors

  • Huaiyu Yang
  • , Yu Shen
  • , Junhua Chen
  • , Qunfeng Jiang
  • , Ying Leng
  • , Jianhua Shen*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Structure-based pharmacophore models were built by using LigandScout and used for virtual screening of the SPECS database to identify new potential 11β-HSD1 inhibitors. As a refinement of the results obtained from virtual 3D pharmacophore screening, the best fitting virtual hits were subjected to docking study. The resulting compounds were tested in an enzyme assay and revealed several compounds with novel scaffolds that show sub-micromolar activity and high selectivity for 11β-HSD1 against 11β-HSD2.

Original languageEnglish
Pages (from-to)1167-1171
Number of pages5
JournalEuropean Journal of Medicinal Chemistry
Volume44
Issue number3
DOIs
StatePublished - Mar 2009
Externally publishedYes

Keywords

  • 11β-HSD1
  • 11β-HSD2
  • Docking
  • Inhibitor
  • Pharmacophore

Fingerprint

Dive into the research topics of 'Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors'. Together they form a unique fingerprint.

Cite this